Benzinga | Jan 25, 2021 08:14AM EST

BMO Capital Downgrades Kodiak Sciences to Market Perform, Raises Price Target to $148

BMO Capital analyst Matthew Luchini downgrades Kodiak Sciences (NASDAQ:KOD) from Outperform to Market Perform and raises the price target from $145 to $148.